The Patent Finder

Terms ending in 2043

Vantis Vascular, Inc.

Every in-force patent on Vantis Vascular, Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,964,091Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
In force
 · High confidence
Vantis Vascular, Inc.In forceHigh confidence
US 12,226,564Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
In force
 · High confidence
Vantis Vascular, Inc.In forceHigh confidence
US 12,390,572Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
In force
 · High confidence
Vantis Vascular, Inc.In forceHigh confidence
US 12,569,608Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
In force
 · Medium confidence
Vantis Vascular, Inc.In forceMedium confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited